Pfizer seeks to improve breast cancer outcomes in Sub-Saharan AfricaWith help from Conquer Cancer’s EveryGrant and ASCO’s Sub-Saharan Africa Regional Council, Pfizer awards grants to seven countries May 30, 2025Vol.51 No.21By Claire Marie Porter
Trials & Tribulations The other side of the patient portal: Reflections from a cancer center leader May 30, 2025Vol.51 No.21By Ruben A. Mesa
Trials & Tribulations Surviving cancer is often not a patient’s most challenging battle May 30, 2025Vol.51 No.21By Boris C. Pasche
Regulatory News ODAC marathon: Committee charges through a pileup of clinical questions in a two-day, four-application session May 23, 2025Vol.51 No.20By Jacquelyn Cobb
Trials & Tribulations Biden’s diagnosis is unfortunate but—statistically—not surprisingOf the 384 men serving in Congress, 48 are likely to be diagnosed with prostate cancer in their lifetime May 23, 2025Vol.51 No.20By Peter Nelson
Trials & Tribulations Unlocking the future of precision medicine:The untapped power of RNA May 23, 2025Vol.51 No.20By Eric Lefkofsky and Norman E. "Ned" Sharpless
A new AI tool enables speedy use of ASCO guidelines, eliminating typical errors May 23, 2025Vol.51 No.20By Claire Marie Porter
PAMN becomes CMCA—the Cancer Marketing & Communications Association—as its size and scope expand May 23, 2025Vol.51 No.20By Jacquelyn Cobb
Sponsored Harnessing big data and AI to combat colorectal cancer May 23, 2025Vol.51 No.20By Enrique Velazquez Villarreal
FreeIn the Archives Highlights in neuroendocrine cancer survivorship, research, and prevention in the Cancer History Project May 23, 2025Vol.51 No.20
